Evidence map›Paper›PMID 31281537›Full record

ArticleTheranostics2019

Survey of the translation shifts in hepatocellular carcinoma with ribosome profiling.

Qin Zou, Zhengtao Xiao, Rongyao Huang, Xin Wang, Xun Wang, Haitao Zhao, Xuerui Yang

Abstract read
In one paragraph

Article in Theranostics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. LFPM inhibition of RING1-mediated p53Cell death and differentiation · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Proteomic analysis of DEN and CClScientific reports · 2024
    Article
  9. Article
  10. Review
  11. Review
  12. The c-Src/LIST Positive Feedback Loop Sustains Tumor Progression and Chemoresistance.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qin ZouMOE Key Laboratory of Bioinformatics, Tsinghua University, Beijing 100084, China.
Zhengtao XiaoMOE Key Laboratory of Bioinformatics, Tsinghua University, Beijing 100084, China.
Rongyao HuangMOE Key Laboratory of Bioinformatics, Tsinghua University, Beijing 100084, China.
Xin WangMOE Key Laboratory of Bioinformatics, Tsinghua University, Beijing 100084, China.
Xun WangDepartment of Hepatobiliary Surgery, The General Hospital of Chinese People's Liberation Army, Beijing 100853, China.
Haitao ZhaoDepartment of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Xuerui YangMOE Key Laboratory of Bioinformatics, Tsinghua University, Beijing 100084, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the critical position of translation in the multilevel gene expression regulation program, high-resolution and genome-wide view of the landscape of RNA translation in solid tumors is still limited.

Indexed as

AnimalsCarcinoma, HepatocellularCell Line, TumorFemaleHumansLiver NeoplasmsMaleProtein BiosynthesisRibosomeshepatocellular carcinomaribosome profilingRNA translationtranslation efficiencytranslatome

Identifiers

PMID31281537
PMCPMC6592166

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.